Why Partner in 2025?

With the explosion of groundbreaking news, investment, and extremely promising clinical results ripping through the GLP-1 space, 2024 was the perfect time to build meaningful relationships with key thought-leaders to understand how to aid them in developing their pipelines toward commercialization.

Returning next year, the GLP-1-Based Therapeutics Summit remains as the exclusive gathering for key biopharma players sharing a common goal: to crystallize pipeline strategy and indication expansion.

Next year's meeting will offer a unique opportunity to elevate your company’s influence with our bespoke partnership opportunities to ensure you capitalize on this rapidly growing market while supporting the development of GLP-1-based therapeutics.

Partner in 2025 to:

GLP-1-Based Therapeutics Summit

Position Yourself as an Industry Thought Leader
Seize this opportunity to position yourself as a prominent authority within the market, by capturing the attention of key decision-makers in the GLP-1 space. By sharing your knowledge, insights, and solutions, you can establish yourself as a trusted leader in the field.

GLP-1-Based Therapeutics Summit

Expand Brand Awareness
Amplify your presence and extend your reach to new clients by taking advantage of distinctive branding opportunities before and during the conference. Leverage our platform to enhance your visibility, leaving a lasting impression that resonates with GLP-1 developers.

GLP-1-Based Therapeutics Summit

Harness Market Intelligence
Gain valuable insights into the solutions and services that biopharma companies will be investing in to facilitate pipeline development in 2025. Armed with this market intelligence, you can align your offerings, ensuring that they meet the evolving needs of GLP-1 developers.

Who Our 2024 Sponsors Met:

Audience - GLP-1-Based Therapeutics Summit

Companies From Our 2024 Expert Speaker Faculty Included: